Results 41 to 50 of about 6,660 (205)
Incidence of Galactorrhea in Young Women Using Depot-Medroxyprogesterone Acetate
The Scientific World Journal, 2006 Galactorrhea is rarely mentioned as a possible side effect of the use of Depot-Medroxyprogesterone Acetate (DMPA). Over the last few years, we have noticed an increased number of patients complaining of galactorrhea. A review of clinical data showed that
Hatim A. Omar +4 more
doaj +1 more source
Trazodone induced euprolactinemic galactorrhea – a case report
European Psychiatry, 2023 Introduction Trazodone is an antidepressant that exerts its effect through serotonin reuptake inhibition and 5-HT2A and 5-HT2C receptor antagonism. Galactorrhea, as well as the increase in prolactin levels, have been seldom related to antidepressants ...
D. Mortágua, D. Rafaela
doaj +1 more source
Endocrine journal, 2018 The clinical influence of macroprolactin (MPRL) is not clearly understood and the rate of patients potentially affected by MPRL is unknown. We investigated the influence of MPRL on the onset of galactorrhea and estimated the rate of patients with a ...
K. Aisaka +8 more
semanticscholar +1 more source
Unilateral galactorrhea associated with low-dose escitalopram
Indian Journal of Psychological Medicine, 2014 Galactorrhea is a rare adverse effect of selective serotonin reuptake inhibitor treatment. We report a 27-year-old woman who developed unilateral breast engorgement with galactorrhea 18 days after initiation of escitalopram (10 mg/day).
P Bangalore Ravi +2 more
doaj +1 more source
Galactorrhea Induced by Risperidone
Internal medicine, 2019 An 87-year-old man with Alzheimer-type dementia presented to our hospital with pain in the right breast. A physical examination revealed nipple discharge and gynecomastia of the right breast (Picture 1, 2, arrows).
S. Sakaguchi, K. Aizawa
semanticscholar +1 more source
Risk Management and Insurance Review, EarlyView.Abstract This study examines whether underwriting methods—representation, medical examination, extra premiums, and coverage—effectively mitigate adverse selection using data from an insurance company. Regarding representation, we focus on statements disclosing pre‐existing medical conditions.
Chia‐Ling Ho +3 more
wiley +1 more source
Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders
Endocrine Regulations, 2022 Proton pump inhibitors (PPIs) are the most widely prescribed medications in the world. According to numerous studies, PPIs have been linked to hyperprolactinemia, which can lead to a variety of sexual and reproductive issues.
Ashfaq Muhammad +2 more
doaj +1 more source
Nigerian Medical Journal, 2016 Background: Galactorrhea is a common manifestation of hyperprolactinemia but may not always be present in women with hyperprolactinemia. This study was, therefore, undertaken to assess the serum prolactin levels of infertile women presenting with ...
E. Ugwa +8 more
semanticscholar +1 more source
Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma
Clinical and Translational Medicine, Volume 16, Issue 5, May 2026.Retroperitoneal sarcoma cells can secrete prolactin into the bloodstream, inducing hyperprolactinaemia, which subsequently triggers metabolic reprogramming, such as glucose metabolism. SOX4 can function as a transcription factor that facilitates PRL transcription.
Fu'an Xie +21 more
wiley +1 more source
DRD2 Deficiency Underlies Pituitary Adenoma Dependent on Escherichia coli Translocation from the Gut
Advanced Science, Volume 13, Issue 24, 27 April 2026.Dopamine receptor D2 (DRD2) deficiency disrupts epithelial barrier integrity in both the gut and pituitary gland, facilitating translocation of gut‐derived Escherichia coli into pituitary tissue. Intratumoral E. coli are phagocytosed by microglia, triggering GSDMD‐dependent pyroptosis and HMGB1 release, which subsequently activates MAPK signaling to ...
Xian‐jun Su +16 more
wiley +1 more source